Application of terlipressin in the treatment of esophagogastric variceal bleeding in liver cirrhosis
10.3969/j.issn.1001-5256.2019.10.038
- VernacularTitle:特利加压素在肝硬化食管胃静脉曲张出血中的应用
- Author:
Xiaolu LI
1
;
Lei LI
Author Information
1. Department of Gastroenterology and Hepatology, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China
- Publication Type:Research Article
- Keywords:
liver cirrhosis;
terlipressin;
esophageal and gastric varices
- From:
Journal of Clinical Hepatology
2019;35(10):2308-2311
- CountryChina
- Language:Chinese
-
Abstract:
Esophagogastric variceal bleeding (EVB) is a common fatal complication secondary to cirrhotic portal hypertension. Terlipressin can shrink visceral blood vessels, reduce portal pressure, and increase renal perfusion and is mainly used in the treatment of EVB. This article summarizes the mechanism of action and clinical effect of terlipressin in the treatment of EVB in liver cirrhosis and points out that if conditions permit, terlipressin combined with endoscopic variceal ligation should be the preferred treatment method for EVB.
